Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas.

Calvete O, Garcia-Pavia P, Domínguez F, Mosteiro L, Pérez-Cabornero L, Cantalapiedra D, Zorio E, Ramón Y Cajal T, Crespo-Leiro MG, Teulé Á, Lázaro C, Morente MM, Urioste M, Benitez J.

J Am Heart Assoc. 2019 Sep 17;8(18):e012875. doi: 10.1161/JAHA.119.012875. Epub 2019 Sep 12.

2.

Arrhythmogenic cardiomyopathy with left ventricular involvement versus ischemic heart disease: lessons learned from the family study and the reviewed autopsy of a young male.

Molina P, Sanz-Sánchez J, Fenollosa M, Martínez-Matilla M, Giner J, Zorio E.

Forensic Sci Res. 2019 Aug 19;4(3):274-279. doi: 10.1080/20961790.2019.1616247. eCollection 2019.

3.

Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy.

Ochoa JP, Sabater-Molina M, García-Pinilla JM, Mogensen J, Restrepo-Córdoba A, Palomino-Doza J, Villacorta E, Martinez-Moreno M, Ramos-Maqueda J, Zorio E, Peña-Peña ML, García-Granja PE, Rodríguez-Palomares JF, Cárdenas-Reyes IJ, de la Torre-Carpente MM, Bautista-Pavés A, Akhtar MM, Cicerchia MN, Bilbao-Quesada R, Mogollón-Jimenez MV, Salazar-Mendiguchía J, Mesa Latorre JM, Arnaez B, Olavarri-Miguel I, Fuentes-Cañamero ME, Lamounier A Jr, Pérez Ruiz JM, Climent-Payá V, Pérez-Sanchez I, Trujillo-Quintero JP, Lopes LR, Repáraz-Andrade A, Marín-Iglesias R, Rodriguez-Vilela A, Sandín-Fuentes M, Garrote JA, Cortel-Fuster A, Lopez-Garrido M, Fontalba-Romero A, Ripoll-Vera T, Llano-Rivas I, Fernandez-Fernandez X, Isidoro-García M, Garcia-Giustiniani D, Barriales-Villa R, Ortiz-Genga M, García-Pavía P, Elliott PM, Gimeno JR, Monserrat L.

J Am Coll Cardiol. 2018 Nov 13;72(20):2457-2467. doi: 10.1016/j.jacc.2018.10.001.

4.

Follow-up and prognosis of HCM.

Dominguez F, Sanz-Sánchez J, García-Pavía P, Zorio E.

Glob Cardiol Sci Pract. 2018 Aug 12;2018(3):33. doi: 10.21542/gcsp.2018.33. Review. No abstract available.

5.

Left ventricular myocardial dysfunction in arrhythmogenic cardiomyopathy with left ventricular involvement: A door to improving diagnosis.

Vives-Gilabert Y, Sanz-Sánchez J, Molina P, Cebrián A, Igual B, Calvillo-Batllés P, Domingo D, Millet J, Martínez-Dolz L, Castells F, Zorio E.

Int J Cardiol. 2019 Jan 1;274:237-244. doi: 10.1016/j.ijcard.2018.09.024. Epub 2018 Sep 10.

6.

Thickness and an Altered miRNA Expression in the Epicardial Adipose Tissue Is Associated With Coronary Heart Disease in Sudden Death Victims.

Marí-Alexandre J, Barceló-Molina M, Sanz-Sánchez J, Molina P, Sancho J, Abellán Y, Santaolaria-Ayora ML, Giner J, Martínez-Dolz L, Estelles A, Braza-Boïls A, Zorio E.

Rev Esp Cardiol (Engl Ed). 2019 Jan;72(1):30-39. doi: 10.1016/j.rec.2017.12.007. Epub 2018 Feb 10. English, Spanish.

PMID:
29439878
7.

Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation.

Dominguez F, Climent V, Zorio E, Ripoll-Vera T, Salazar-Mendiguchía J, García-Pinilla JM, Urbano-Moral JA, Fernández-Fernández X, Lopez-Cuenca D, Ajo-Ferrer R, Sanz-Sanchez J, Gomez-Perez Y, López-Garrido MA, Barriales-Villa R, Gimeno JR, Garcia-Pavia P.

Int J Cardiol. 2017 Dec 1;248:232-238. doi: 10.1016/j.ijcard.2017.08.010. Epub 2017 Aug 7.

PMID:
28811092
8.

RyR2R420Q catecholaminergic polymorphic ventricular tachycardia mutation induces bradycardia by disturbing the coupled clock pacemaker mechanism.

Wang YY, Mesirca P, Marqués-Sulé E, Zahradnikova A Jr, Villejoubert O, D'Ocon P, Ruiz C, Domingo D, Zorio E, Mangoni ME, Benitah JP, Gómez AM.

JCI Insight. 2017 Apr 20;2(8). pii: 91872. doi: 10.1172/jci.insight.91872. eCollection 2017 Apr 20.

9.

Postmortem genetic testing should be recommended in sudden cardiac death cases due to thoracic aortic dissection.

Gago-Díaz M, Ramos-Luis E, Zoppis S, Zorio E, Molina P, Braza-Boïls A, Giner J, Sobrino B, Amigo J, Blanco-Verea A, Carracedo Á, Brion M.

Int J Legal Med. 2017 Sep;131(5):1211-1219. doi: 10.1007/s00414-017-1583-9. Epub 2017 Apr 8.

PMID:
28391405
10.

Myocardial Extracellular Volume Is Not Associated With Malignant Ventricular Arrhythmias in High-risk Hypertrophic Cardiomyopathy.

Mirelis JG, Sánchez-González J, Zorio E, Ripoll-Vera T, Salguero-Bodes R, Filgueiras-Rama D, González-López E, Gallego-Delgado M, Fernández-Jiménez R, Soleto MJ, Núñez J, Pizarro G, Sanz J, Fuster V, García-Pavía P, Ibáñez B.

Rev Esp Cardiol (Engl Ed). 2017 Nov;70(11):933-940. doi: 10.1016/j.rec.2017.01.026. Epub 2017 Mar 22. English, Spanish.

PMID:
28341414
11.

Value of the "Standing Test" in the Diagnosis and Evaluation of Beta-blocker Therapy Response in Long QT Syndrome.

Muñoz-Esparza C, Zorio E, Domingo Valero D, Peñafiel-Verdú P, Sánchez-Muñoz JJ, García-Molina E, Sabater M, Navarro M, San-Román I, Pérez I, Santos JJ, Cabañas-Perianes V, Valdés M, Pascual D, García-Alberola A, Gimeno Blanes JR.

Rev Esp Cardiol (Engl Ed). 2017 Nov;70(11):907-914. doi: 10.1016/j.rec.2017.01.006. Epub 2017 Feb 21. English, Spanish.

PMID:
28233664
12.

Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies.

Ortiz-Genga MF, Cuenca S, Dal Ferro M, Zorio E, Salgado-Aranda R, Climent V, Padrón-Barthe L, Duro-Aguado I, Jiménez-Jáimez J, Hidalgo-Olivares VM, García-Campo E, Lanzillo C, Suárez-Mier MP, Yonath H, Marcos-Alonso S, Ochoa JP, Santomé JL, García-Giustiniani D, Rodríguez-Garrido JL, Domínguez F, Merlo M, Palomino J, Peña ML, Trujillo JP, Martín-Vila A, Stolfo D, Molina P, Lara-Pezzi E, Calvo-Iglesias FE, Nof E, Calò L, Barriales-Villa R, Gimeno-Blanes JR, Arad M, García-Pavía P, Monserrat L.

J Am Coll Cardiol. 2016 Dec 6;68(22):2440-2451. doi: 10.1016/j.jacc.2016.09.927.

13.

Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease.

Braza-Boïls A, Marí-Alexandre J, Molina P, Arnau MA, Barceló-Molina M, Domingo D, Girbes J, Giner J, Martínez-Dolz L, Zorio E.

Liver Int. 2016 Aug;36(8):1221-9. doi: 10.1111/liv.13097. Epub 2016 Mar 23.

PMID:
26901384
14.

Diagnostic yield of molecular autopsy in patients with sudden arrhythmic death syndrome using targeted exome sequencing.

Nunn LM, Lopes LR, Syrris P, Murphy C, Plagnol V, Firman E, Dalageorgou C, Zorio E, Domingo D, Murday V, Findlay I, Duncan A, Carr-White G, Robert L, Bueser T, Langman C, Fynn SP, Goddard M, White A, Bundgaard H, Ferrero-Miliani L, Wheeldon N, Suvarna SK, O'Beirne A, Lowe MD, McKenna WJ, Elliott PM, Lambiase PD.

Europace. 2016 Jun;18(6):888-96. doi: 10.1093/europace/euv285. Epub 2015 Oct 25.

15.

Phenotypic Patterns of Cardiomyopathy Caused by Mutations in the Desmin Gene. A Clinical and Genetic Study in Two Inherited Heart Disease Units.

Ripoll-Vera T, Zorio E, Gámez JM, Molina P, Govea N, Crémer D.

Rev Esp Cardiol (Engl Ed). 2015 Nov;68(11):1027-9. doi: 10.1016/j.rec.2015.07.007. Epub 2015 Oct 1. No abstract available.

PMID:
26431784
16.

Sensitivity and negative predictive value of treadmill exercise stress testing for the diagnosis of catecholaminergic polymorphic ventricular tachycardia. Response.

Domingo D, López-Vilella R, Arnau MÁ, Zorio E.

Rev Esp Cardiol (Engl Ed). 2015 Jun;68(6):546-7. doi: 10.1016/j.rec.2015.02.011. Epub 2015 May 1. No abstract available.

PMID:
25936659
17.

The genetic background of left ventricular hypertrabeculation/noncompaction remains vague. Response.

Rodríguez-Serrano M, Domingo D, Igual B, Zorio E.

Rev Esp Cardiol (Engl Ed). 2015 Feb;68(2):167-8. doi: 10.1016/j.rec.2014.10.001. Epub 2014 Dec 15. No abstract available.

PMID:
25522834
18.

Non-ventricular, Clinical, and Functional Features of the RyR2(R420Q) Mutation Causing Catecholaminergic Polymorphic Ventricular Tachycardia.

Domingo D, Neco P, Fernández-Pons E, Zissimopoulos S, Molina P, Olagüe J, Suárez-Mier MP, Lai FA, Gómez AM, Zorio E.

Rev Esp Cardiol (Engl Ed). 2015 May;68(5):398-407. doi: 10.1016/j.rec.2014.04.023. Epub 2014 Nov 29.

PMID:
25440180
19.

A new mutation in the ryanodine receptor 2 gene (RYR2 C2277R) as a cause catecholaminergic polymorphic ventricular tachycardia.

Domingo D, López-Vilella R, Arnau MÁ, Cano Ó, Fernández-Pons E, Zorio E.

Rev Esp Cardiol (Engl Ed). 2015 Jan;68(1):71-3. doi: 10.1016/j.rec.2014.07.022. Epub 2014 Nov 27. No abstract available.

PMID:
25435091
20.

Familial left ventricular noncompaction associated with a novel mutation in the alpha-cardiac actin gene.

Rodríguez-Serrano M, Domingo D, Igual B, Cano A, Medina P, Zorio E.

Rev Esp Cardiol (Engl Ed). 2014 Oct;67(10):857-9. doi: 10.1016/j.rec.2014.05.015. Epub 2014 Sep 5. No abstract available.

PMID:
25201647
21.

Role of novel DSP_p.Q986X genetic variation in arrhythmogenic right ventricular cardiomyopathy.

Campuzano O, Alcalde M, Berne P, Zorio E, Iglesias A, Navarro-Manchón J, Brugada J, Brugada R.

Eur J Med Genet. 2013 Oct;56(10):541-5. doi: 10.1016/j.ejmg.2013.08.001. Epub 2013 Aug 14.

PMID:
23954618
22.

Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.

Núñez L, Gimeno-Blanes JR, Rodríguez-García MI, Monserrat L, Zorio E, Coats C, McGregor CG, Hernandez del Rincón JP, Castro-Beiras A, Hermida-Prieto M.

Circ J. 2013;77(9):2358-65. Epub 2013 Jun 19.

23.

Flecainide, a therapeutic option in a patient with long QT syndrome type 3 caused by the heterozygous V411M mutation in the SCN5A gene.

Carrasco JI, Izquierdo I, Medina P, Arnau MÁ, Salvador A, Zorio E.

Rev Esp Cardiol (Engl Ed). 2012 Nov;65(11):1058-9. doi: 10.1016/j.recesp.2012.03.014. Epub 2012 Jun 19. English, Spanish. No abstract available.

PMID:
22721569
24.

Paradoxical effect of increased diastolic Ca(2+) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia.

Neco P, Torrente AG, Mesirca P, Zorio E, Liu N, Priori SG, Napolitano C, Richard S, Benitah JP, Mangoni ME, Gómez AM.

Circulation. 2012 Jul 24;126(4):392-401. doi: 10.1161/CIRCULATIONAHA.111.075382. Epub 2012 Jun 18.

25.

Role of microRNAs in gynecological pathology.

Gilabert-Estelles J, Braza-Boils A, Ramon LA, Zorio E, Medina P, Espana F, Estelles A.

Curr Med Chem. 2012;19(15):2406-13. Review.

PMID:
22455593
26.

Association between red blood cell distribution width and the risk of future cardiovascular events.

Vaya A, Hernández JL, Zorio E, Bautista D.

Clin Hemorheol Microcirc. 2012;50(3):221-5. doi: 10.3233/CH-2011-1428.

PMID:
22240356
27.

[Arrhythmogenic cardiomyopathy. Patterns of ventricular involvement using cardiac magnetic resonance].

Igual B, Zorio E, Maceira A, Estornell J, Lopez-Lereu MP, Monmeneu JV, Quesada A, Navarro J, Mas F, Salvador A.

Rev Esp Cardiol. 2011 Dec;64(12):1114-22. doi: 10.1016/j.recesp.2011.07.014. Epub 2011 Oct 24. Spanish.

28.

[Left dominant arrhythmogenic cardiomyopathy caused by a novel nonsense mutation in desmoplakin].

Navarro-Manchón J, Fernández E, Igual B, Asimaki A, Syrris P, Osca J, Salvador A, Zorio E.

Rev Esp Cardiol. 2011 Jun;64(6):530-4. doi: 10.1016/j.recesp.2010.10.020. Epub 2011 Mar 31. Spanish.

29.

Prognostic value of glomerular filtration rate 1 year after heart transplantation.

Navarro-Manchón J, Martínez-Dolz L, Almenar L, Moro JA, Zorio E, Raso R, Buendía F, Sánchez-Lázaro I, Agüero J, Salvador A.

Rev Esp Cardiol. 2010 May;63(5):564-70.

30.

Laparoscopic approach to right diaphragmatic endometriosis with argon laser: case report.

Gilabert-Estelles J, Zorio E, Castello JM, Estelles A, Gilabert-Aguilar J.

J Minim Invasive Gynecol. 2010 Jan-Feb;17(1):124-7. doi: 10.1016/j.jmig.2009.10.011.

PMID:
20129348
31.

Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis.

Roldán V, Ordoñez A, Marín F, Zorio E, Soria JM, Miñano A, España F, González-Conejero R, Pineda J, Estellés A, Fontcuberta J, Vicente V, Corral J.

Thromb Haemost. 2009 Mar;101(3):483-6.

PMID:
19277409
32.

Insights into the role of microRNAs in cardiac diseases: from biological signalling to therapeutic targets.

Zorio E, Medina P, Rueda J, Millán JM, Arnau MA, Beneyto M, Marín F, Gimeno JR, Osca J, Salvador A, España F, Estellés A.

Cardiovasc Hematol Agents Med Chem. 2009 Jan;7(1):82-90. Review.

PMID:
19149547
33.

Endothelial protein C receptor polymorphisms and risk of myocardial infarction.

Medina P, Navarro S, Corral J, Zorio E, Roldán V, Estellés A, Santamaría A, Marín F, Rueda J, Bertina RM, España F; RECAVA Thrombosis Groups.

Haematologica. 2008 Sep;93(9):1358-63. doi: 10.3324/haematol.13066.

34.

The -589C>T polymorphism in the interleukin-4 gene (IL-4) is associated with a reduced risk of myocardial infarction in young individuals.

Paffen E, Medina P, de Visser MC, van Wijngaarden A, Zorio E, Estellés A, Rosendaal FR, España F, Bertina RM, Doggen CJ.

J Thromb Haemost. 2008 Oct;6(10):1633-8. doi: 10.1111/j.1538-7836.2008.03096.x. Epub 2008 Jul 25.

35.

Haemorheological parameters in young patients with acute myocardial infarction.

Zorio E, Murado J, Arizo D, Rueda J, Corella D, Simó M, Vayá A.

Clin Hemorheol Microcirc. 2008;39(1-4):33-41.

PMID:
18503108
36.

Fibrinolysis: the key to new pathogenetic mechanisms.

Zorio E, Gilabert-Estellés J, España F, Ramón LA, Cosín R, Estellés A.

Curr Med Chem. 2008;15(9):923-9. Review.

PMID:
18473800
37.

Treatment in a haemophiliac A patient with paroxysmal atrial fibrillation and ischemic heart disease.

Cid AR, Zorio E, Haya S, Zúñiga P, Rueda J, Casaña P, Cabrera N, Arnau MA, Aznar JA.

Haemophilia. 2007 Nov;13(6):760-2. No abstract available.

PMID:
17973853
38.

[Viral hepatitis C-related fibrosing cholestatic hepatitis after cardiac transplantation].

Izquierdo MT, Almenar L, Zorio E, Martínez-Dolz L.

Med Clin (Barc). 2007 Jun 16;129(3):117-8. Spanish. No abstract available.

PMID:
17594865
39.

The role of protein C inhibitor in human reproduction.

España F, Navarro S, Medina P, Zorio E, Estellés A.

Semin Thromb Hemost. 2007 Feb;33(1):41-5. Review.

PMID:
17253188
40.

[Impact of diabetes mellitus on heart transplant recipients].

Moro JA, Martínez-Dolz L, Almenar L, Martínez-Ortiz L, Chamorro C, García C, Arnau MA, Rueda J, Zorio E, Salvador A.

Rev Esp Cardiol. 2006 Oct;59(10):1033-7. Spanish.

41.

Variations in the frequency and type of infections in heart transplantation according to the immunosuppression regimen.

Agüero J, Almenar L, Martinez-Dolz L, Chamorro C, Moro J, Zorio E, Arnau MA, Rueda J, Izquierdo M, Salvador A.

Transplant Proc. 2006 Oct;38(8):2558-9.

PMID:
17098001
42.

Evolutional changes in maintenance immunosuppression following heart transplantation.

Sánchez-Lázaro I, Almenar L, Martínez-Dolz L, Chamorro C, Moro J, Agüero J, Rueda J, Zorio E, Arnau MA, Salvador A.

Transplant Proc. 2006 Oct;38(8):2553-4.

PMID:
17097999
43.

Influence of immunosuppression regimen on heart transplantation survival.

Agüero J, Almenar L, Martínez-Dolz L, Chamorro C, Moro J, Rueda J, Arnau MA, Zorio E, Izquierdo M, Salvador A.

Transplant Proc. 2006 Oct;38(8):2550-2.

PMID:
17097998
44.

Induction therapy with daclizumab in heart transplantation--how many doses?

Ortiz V, Almenar L, Martínez-Dolz L, Zorio E, Chamorro C, Moro J, Agüero J, Rueda J, Arnau MA, Salvador A.

Transplant Proc. 2006 Oct;38(8):2541-3.

PMID:
17097995
45.

Does amiodarone influence early mortality in heart transplantation?

Sánchez-Lázaro IJ, Almenar L, Martinez-Dolz L, Chamorro C, Moro J, Agüero J, Rueda J, Zorio E, Arnau MA, Salvador A.

Transplant Proc. 2006 Oct;38(8):2537-8.

PMID:
17097993
46.

Is there a correlation between brain naturietic peptide levels and echocardiographic and hemodynamic parameters in heart transplant patients?

Almenar L, Arnau MA, Martínez-Dolz L, Hervás I, Osa A, Miró V, Sánchez E, Zorio E, Rueda J, Mateo A, Salvador A.

Transplant Proc. 2006 Oct;38(8):2534-6.

PMID:
17097992
47.

Circulating activated protein C is reduced in young survivors of myocardial infarction and inversely correlates with the severity of coronary lesions.

Zorio E, Navarro S, Medina P, Estellés A, Osa A, Rueda J, Cubillo P, Aznar J, España F.

J Thromb Haemost. 2006 Jul;4(7):1530-6.

48.

Lipoprotein (a) in young individuals as a marker of the presence of ischemic heart disease and the severity of coronary lesions.

Zorio E, Falco C, Arnau MA, España F, Osa A, Ramon LA, Castello R, Almenar L, Palencia MA, Estelles A.

Haematologica. 2006 Apr;91(4):562-5.

49.

Influence of induction therapy on rejection and survival in heart transplantation.

Almenar L, García-Palomar C, Martínez-Dolz L, Chamorro C, Moro J, Zorio E, Arnau MA, Rueda J, Osa A, Cardo ML.

Transplant Proc. 2005 Nov;37(9):4024-7.

PMID:
16386616
50.

Risk factors affecting survival in heart transplant patients.

Almenar L, Cardo ML, Martínez-Dolz L, García-Palomar C, Rueda J, Zorio E, Arnau MA, Osa A, Palencia M.

Transplant Proc. 2005 Nov;37(9):4011-3.

PMID:
16386612

Supplemental Content

Support Center